Evidence map›Paper›PMID 32437299›Full record

ReviewCirculation research2020

Metabolic Inflammation and Insulin Resistance in Obesity.

Huaizhu Wu, Christie M Ballantyne

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04802044 (COVID-19, Aging, and Cardiometabolic Risk Factors), which is not on this map. Cited by 618 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
618citing papers in PubMed, 5 pooled it
66.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04802044 unknown statusnot on this map

COVID-19, Aging, and Cardiometabolic Risk Factors (CARAMEL) Study: Integrating Aging, Cardiovascular, Metabolic, and Immunological Studies to Unravel COVID-19 Pathophysiology

TypeobservationalSponsorIndonesia UniversityRan2020 to 2023Enrolled440ConditionsCovid19, Obesity, Diabetes Mellitus, Aging
3 · Its place in the literature

Who cites it

618 citing papers in PubMed, 5 syntheses or guidelines pooled it, 928 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Gut microbes · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. AdipocyteCells · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

558 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Huaizhu WuFrom the Department of Medicine (H.W., C.M.B.), Baylor College of Medicine, Houston, TX.
Christie M BallantyneFrom the Department of Medicine (H.W., C.M.B.), Baylor College of Medicine, Houston, TX.
Baylor College of Medicine · US

Funding

Monocyte Activation and the Role of CD11c in obesity-linked metabolic syndromeR01HL098839 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WU, HUAIZHU · 2010 to 2019
$3.2M
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular DiseaseR01HL134320 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI BALLANTYNE, CHRISTIE MITCHELL, SELVIN, ELIZABETH · 2016 to 2019
$3.1M
Regulation of Type 1 Inflammation in Diet-induced ObesityR01DK121348 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI WU, HUAIZHU · 2020 to 2023
$1.6M
American Heart Association-American Stroke Association 16GRNT30410012NHLBI NIH HHS R01 HL098839NHLBI NIH HHS R01 HL134320NIDDK NIH HHS R01 DK121348
6 · The paper itself

Abstract

Obesity is becoming an epidemic in the United States and worldwide and increases risk for many diseases, particularly insulin resistance, type 2 diabetes mellitus, and cardiovascular disease. The mechanisms linking obesity with these diseases remain incompletely understood. Over the past 2 to 3 decades, it has been recognized that in obesity, inflammation, with increased accumulation and inflammatory polarization of immune cells, takes place in various tissues, including adipose tissue, skeletal muscle, liver, gut, pancreatic islet, and brain and may contribute to obesity-linked metabolic dysfunctions, leading to insulin resistance and type 2 diabetes mellitus. Therapies targeting inflammation have shed light on certain obesity-linked diseases, including type 2 diabetes mellitus and atherosclerotic cardiovascular disease, but remain to be tested further and confirmed in clinical trials. This review focuses on inflammation in adipose tissue and its potential role in insulin resistance associated with obesity.

Indexed as

Insulin ResistanceAnimalsCytokinesHumansObesitySignal TransductionCytokinesadipose tissuediabetes mellitusinflammationinsulin resistanceobesity

Identifiers

PMID32437299
PMCPMC7250139
OpenAlexW3027726841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.